ArticleFrontiers in cell and developmental biology2022

Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach.

Philip Vlummens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.